Wei Ling Florence Lim
LipidALL Technologies (China)(CN)
Publications by Year
Research Areas
Alzheimer's disease research and treatments, Cholesterol and Lipid Metabolism, Metabolomics and Mass Spectrometry Studies, Diabetes, Cardiovascular Risks, and Lipoproteins, Liver Disease Diagnosis and Treatment
Most-Cited Works
- → Concordant peripheral lipidome signatures in two large clinical studies of Alzheimer’s disease(2020)156 cited
- → Sodium Butyrate Reduces Brain Amyloid-β Levels and Improves Cognitive Memory Performance in an Alzheimer’s Disease Transgenic Mouse Model at an Early Disease Stage(2020)141 cited
- → Alzheimer’s Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies—Gains from AIBL and DIAN Cohort Studies(2018)129 cited
- → Comprehensive genetic analysis of the human lipidome identifies loci associated with lipid homeostasis with links to coronary artery disease(2022)94 cited
- → The Involvement of Lipids in Alzheimer's Disease(2014)64 cited
- → APOE Genotype Results in Differential Effects on the Peripheral Clearance of Amyloid-β42 in APOE Knock-in and Knock-out Mice(2010)55 cited
- → Plasma Phospholipid and Sphingolipid Alterations in Presenilin1 Mutation Carriers: A Pilot Study(2016)52 cited
- → APOE ε2 resilience for Alzheimer's disease is mediated by plasma lipid species: Analysis of three independent cohort studies(2022)44 cited
- → Plasma metabolites associated with biomarker evidence of neurodegeneration in cognitively normal older adults(2020)41 cited
- → Profiling Brain and Plasma Lipids in Human APOE ε2, ε3, and ε4 Knock-in Mice Using Electrospray Ionization Mass Spectrometry(2010)37 cited